BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29793178)

  • 1. Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer.
    Sadeghi MR; Jeddi F; Soozangar N; Somi MH; Shirmohamadi M; Khaze V; Samadi N
    Biomed Pharmacother; 2018 Aug; 104():458-464. PubMed ID: 29793178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer.
    Jeddi F; Soozangar N; Sadeghi MR; Somi MH; Shirmohamadi M; Eftekhar-Sadat AT; Samadi N
    Biomed Pharmacother; 2018 Jan; 97():286-292. PubMed ID: 29091877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
    Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The level of S-glutathionylated protein is a predictor for metastasis in colorectal cancer and correlated with those of Nrf2/Keap1 pathway.
    Chang LC; Fan CW; Tseng WK; Hua CC
    Biomarkers; 2021 Dec; 26(8):780-787. PubMed ID: 34704878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and correlation of NRF2, KEAP1, NQO-1 and HO-1 in advanced squamous cell carcinoma of the larynx and their association with clinicopathologic features.
    Li C; Wu H; Wang S; Zhu J
    Mol Med Rep; 2016 Dec; 14(6):5171-5179. PubMed ID: 27840932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
    Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
    Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between the Nrf2/Keap1 pathway and mitochondrial functions in colorectal cancer are affected by metastasis.
    Chang LC; Fan CW; Tseng WK; Hua CC
    Cancer Biomark; 2020; 27(2):163-171. PubMed ID: 31796664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ratio of Hmox1/Nrf2 mRNA Level in the Tumor Tissue Is a Predictor of Distant Metastasis in Colorectal Cancer.
    Chang LC; Fan CW; Tseng WK; Chein HP; Hsieh TY; Chen JR; Hwang CC; Hua CC
    Dis Markers; 2016; 2016():8143465. PubMed ID: 27999449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of thioredoxin/Keap1 protein level is a predictor of distant metastasis in colorectal cancer.
    Chang LC; Fan CW; Tseng WK; Chein HP; Hsieh TY; Chen JR; Hwang CC; Hua CC
    Biomark Med; 2017 Dec; 11(12):1103-1111. PubMed ID: 29053012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
    Sun X; Zuo H; Liu C; Yang Y
    Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of P-glycoprotein by Bajijiasu in vitro and in vivo by activating the Nrf2-mediated signalling pathway.
    Yang X; Hu G; Lv L; Liu T; Qi L; Huang G; You D; Zhao J
    Pharm Biol; 2019 Dec; 57(1):184-192. PubMed ID: 30929555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Keap1/Nrf2 stress response pathway in autophagic vacuolar myopathies.
    Duleh S; Wang X; Komirenko A; Margeta M
    Acta Neuropathol Commun; 2016 Oct; 4(1):115. PubMed ID: 27799074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance.
    Sadeghi MR; Jeddi F; Soozangar N; Somi MH; Samadi N
    Tumour Biol; 2017 Jun; 39(6):1010428317705510. PubMed ID: 28621229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumour/normal tissue ratio of Keap1 protein is a predictor for lymphovascular invasion in colorectal cancer: a correlation study between the Nrf2 and KRas pathways.
    Chang LC; Fan CW; Tseng WK; Chen JR; Hua CC
    Biomarkers; 2022 Nov; 27(7):701-707. PubMed ID: 35830714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
    Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
    FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the Nrf2 and Keap1 proteins and their clinical significance in osteosarcoma.
    Zhang J; Wang X; Wu W; Dang H; Wang B
    Biochem Biophys Res Commun; 2016 Apr; 473(1):42-46. PubMed ID: 26987716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.
    Cho HY; Kim K; Kim YB; Kim H; No JH
    Int J Gynecol Cancer; 2017 Mar; 27(3):412-419. PubMed ID: 28129239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of the KEAP1 gene promoter region in human colorectal cancer.
    Hanada N; Takahata T; Zhou Q; Ye X; Sun R; Itoh J; Ishiguro A; Kijima H; Mimura J; Itoh K; Fukuda S; Saijo Y
    BMC Cancer; 2012 Feb; 12():66. PubMed ID: 22325485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.